About: Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $19.86 (+3.17%)
VOR NASDAQ Vor Biopharma Inc
Vor Biopharma Inc share price
VOR price activity
Last Price
$19.860
Change (24hr)
0.61 USD (3.17%)
Volume
902K
Volume (4w avg)
-
Open
$19.45
Day Range
$18.93 - $20.63
Previous Close
$19.25
Last Trade
03 Nov, 9:09 pm GMT+0
Delayed
03 Nov, 9:09 pm GMT+0
VOR price performance
Delayed
03 Nov, 9:09 pm GMT+0
VOR details
VOR Market Signals